A peptide supplier may provide a mechanistic paper, an in-vitro result or a test on a prototype formula. Those are useful inputs to development, but they answer different questions. A brand preparing a consumer claim has to show that the evidence supports the actual finished product, its wording and the market where it will be sold.
Identify the level of evidence
Material identity and technical data
First confirm the peptide, its supplied concentration and any carrier. A study on a defined molecule cannot automatically be applied to a different salt, premix or finished formula. A COA establishes specified quality attributes for a batch; it is not a clinical study of consumer benefit.
Ingredient or model study
Read the test system, dose, exposure and outcome. Cell or laboratory model results can help select a development direction, but the delivery and concentration in a commercial cosmetic may differ. If a supplier supplies a summary graph without a method or full report, ask for the supporting study before using it in a claim dossier.
Finished-product substantiation
The final formula, pack and directions determine what consumers actually use. The EU’s common criteria for cosmetic claims, Regulation (EU) No 655/2013, require adequate and verifiable evidence and warn against extrapolating ingredient properties to the finished product without support. Regulation (EC) No 1223/2009 also places proof of a claimed effect, where justified by the nature or effect of the cosmetic, in the product information file. The brand’s responsible person should determine the appropriate evidence package.
Check the words before commissioning a test
Write the intended consumer-facing sentence, audience and territory first. A claim about the look or feel of skin asks a different substantiation question from a promise to treat disease or change body structure. In the United States, the FDA explains that cosmetic claims must be truthful and not misleading, while disease and certain structure/function claims can make a product a drug under US law. Legal review should precede publication, especially for cross-border launches.
Questions for the supplier and testing partner
- Which exact ingredient and concentration were studied?
- Was the test performed on the raw material, a prototype or the final formula?
- What was the method, comparator, sample and measured endpoint?
- Can the claim be expressed accurately without overstating the data?
- Who holds the full report and can provide it for market review?
Our cosmetic peptide materials can be discussed within a defined formulation brief. The services page outlines the project stages where sample and specification decisions can be recorded.
Frequently asked questions
Can a raw-material brochure substantiate a finished-cream claim?
It can inform development, but the final claim needs evidence appropriate to the finished cream and the exact wording used.
Is an in-vitro study worthless?
No. It can support a hypothesis or mechanism. Its limits should be stated, and it should not be presented as direct proof of a consumer outcome.
Who is responsible for the final claim?
The business placing the finished product on the market must assess the applicable rules and maintain the required supporting evidence.
Before a claim goes live, have the responsible market team check the exact wording against the complete evidence file.